cbdMD, Inc. (YCBD) Revenue History
Annual and quarterly revenue from 2016 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
YCBD Revenue Growth
YCBD Revenue Analysis (2016–2025)
As of May 8, 2026, cbdMD, Inc. (YCBD) generated trailing twelve-month (TTM) revenue of $14.1 million, reflecting significant decline in growth of -100.0% year-over-year. The most recent quarter (Q1 2026) recorded $0 in revenue, down 100.0% sequentially.
Looking at the longer-term picture, YCBD's 5-year compound annual growth rate (CAGR) stands at -14.5%, indicating revenue contraction over this period. The company achieved its highest annual revenue of $44.5 million in 2021.
When compared to Healthcare sector peers including TLRY (+3.0% YoY), CGC (+6.3% YoY), and ACB (+12.8% YoY), YCBD has underperformed the peer group in terms of revenue growth. Compare YCBD vs TLRY →
YCBD Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| YCBDCurrent | $14M | -100.0% | -14.5% | -11.3% | |
 TLRY | $1.1B | +3.0% | +22.7% | -277.9% | |
 CGC | $269M | +6.3% | -7.6% | -43.5% | |
 ACB | $343M | +12.8% | +5.0% | 1.4% | |
 XXII | $18M | +75.4% | -9.0% | -64.9% | |
 BYFC | $63M | - | - | -38.8% |
YCBD Historical Revenue Data (2016–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $19.2M | -1.5% | $10.8M | 56.5% | $-2,162,590 | -11.3% |
| 2024 | $19.5M | -19.3% | $12.0M | 61.6% | $-3,189,572 | -16.4% |
| 2023 | $24.2M | -31.8% | $15.0M | 62.0% | $-9,268,549 | -38.4% |
| 2022 | $35.4M | -20.4% | $22.3M | 63.1% | $35.8M | 101.1% |
| 2021 | $44.5M | +6.2% | $30.0M | 67.4% | $-19,615,991 | -44.1% |
| 2020 | $41.9M | +77.1% | $26.4M | 63.0% | $-17,581,855 | -42.0% |
| 2019 | $23.7M | +180.9% | $14.5M | 61.4% | $19.1M | 80.9% |
| 2018 | $8.4M | +88.2% | $5.7M | 68.3% | $117K | 1.4% |
| 2017 | $4.5M | +120.3% | $3.1M | 69.7% | $-239,291 | -5.3% |
| 2016 | $2.0M | - | $413K | 20.3% | $-3,733,293 | -183.8% |
See YCBD's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs YCBD Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare YCBD vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonYCBD — Frequently Asked Questions
Quick answers to the most common questions about buying YCBD stock.
Is YCBD's revenue growth accelerating or slowing?
YCBD revenue declined -100.0% year-over-year, contrasting with the 5-year CAGR of -14.5%. TTM revenue fell to $14M. This reverses the prior growth trend.
What is YCBD's long-term revenue growth rate?
cbdMD, Inc.'s 5-year revenue CAGR of -14.5% reflects the variable expansion pattern. Current YoY growth of -100.0% is below this long-term average.
How is YCBD's revenue distributed by segment?
YCBD reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2016-2025 are available for download. Segment mix reveals concentration and diversification trends.